{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:31:55Z","timestamp":1790058715165,"version":"4.0.1"},"reference-count":24,"publisher":"Cold Spring Harbor Laboratory","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Mol Case Stud"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>A 12-yr-old normocalcemic female treated for a ruptured ovarian juvenile granulosa cell tumor at an outside hospital presented for exploratory laparotomy and gross surgical debulking of pelvic recurrence. Morphologically, the tumor was composed of sheets and nests of small blue cells forming cysts of various sizes and focal mucinous differentiation. Epithelial membrane antigen (EMA), patchy inhibin, and strong and diffuse p53 immunoreactivity were also observed. A revised diagnosis of mixed sex cord stromal tumor with heterologous elements was favored because of the inhibin immunoreactivity. Targeted next-generation sequencing of the tumor revealed a <jats:italic>SMARCA4<\/jats:italic> c.1141C&gt;T, p.Arg381Ter (NM_001128849.1) nonsense mutation and an in-frame 18-bp <jats:italic>TP53<\/jats:italic> deletion (c.594_611del18, p.Gly199_Glu204del, NM_001126112.2). Cytogenetic analysis revealed a normal 46,XX karyotype, and OncoScan single-nucleotide polymorphism array analysis demonstrated copy-neutral loss of heterozygosity (CN-LOH) of 19p13.3-19p13.2 and mosaic CN-LOH of 17p13.3-p11.2 encompassing the <jats:italic>SMARCA4<\/jats:italic> and <jats:italic>TP53<\/jats:italic> loci, respectively. Subsequent germline <jats:italic>SMARCA4<\/jats:italic> sequencing confirmed a heterozygous <jats:italic>SMARCA4<\/jats:italic> p.Arg381Ter mutation. In lieu of the molecular findings, the diagnosis was amended to small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). The patient was treated aggressively with paclitaxel, carboplatin, and bevacizumab. She received an autologous stem cell transplant but died 5 mo after SCCOHT diagnosis secondary to complications of the transplant. This case expands the morphologic, immunophenotypic, and genomic spectrum of SCCOHT and highlights how multimodal molecular analysis can assist with the diagnosis and clinical management of SCCOHT patients.<\/jats:p>","DOI":"10.1101\/mcs.a002956","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T13:39:40Z","timestamp":1538401180000},"page":"a002956","source":"Crossref","is-referenced-by-count":9,"title":["Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type"],"prefix":"10.1101","volume":"4","author":[{"given":"Marjorie P.","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-106X","authenticated-orcid":false,"given":"Rajkumar","family":"Venkatramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-420X","authenticated-orcid":false,"given":"Dolores H.","family":"Lopez-Terrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-8576","authenticated-orcid":false,"given":"Angshumoy","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-6464","authenticated-orcid":false,"given":"Ninad","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-0937","authenticated-orcid":false,"given":"Kevin E.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"2021112406072043000_4.5.a002956.1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2350\/15-05-1638-OA.1","article-title":"Integrating molecular testing in the diagnosis and management of children with thyroid lesions","volume":"19","year":"2016","journal-title":"Pediatr Dev Pathol"},{"key":"2021112406072043000_4.5.a002956.2","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/S1470-2045(13)70088-3","article-title":"Extracranial rhabdoid tumours: what we have learned so far and future directions","volume":"14","year":"2013","journal-title":"Lancet Oncol"},{"key":"2021112406072043000_4.5.a002956.3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.humpath.2016.02.015","article-title":"Translocation t(7;12) as the sole chromosomal abnormality resulting in ACTB-GLI1 fusion in pediatric gastric pericytoma","volume":"53","year":"2016","journal-title":"Hum Pathol"},{"key":"2021112406072043000_4.5.a002956.4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/his.12988","article-title":"Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics","volume":"69","year":"2016","journal-title":"Histopathology"},{"key":"2021112406072043000_4.5.a002956.5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","article-title":"Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type","volume":"40","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2021112406072043000_4.5.a002956.6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820101)49:1<188::AID-CNCR2820490137>3.0.CO;2-D"},{"key":"2021112406072043000_4.5.a002956.7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22213"},{"key":"2021112406072043000_4.5.a002956.8","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.18632\/oncotarget.6459","article-title":"Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid\/rhabdoid tumor","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"2021112406072043000_4.5.a002956.9","doi-asserted-by":"publisher","DOI":"10.1002\/path.4362"},{"key":"2021112406072043000_4.5.a002956.10","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-33"},{"key":"2021112406072043000_4.5.a002956.11","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.1.362-376.2004"},{"key":"2021112406072043000_4.5.a002956.12","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2922"},{"key":"2021112406072043000_4.5.a002956.13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/modpathol.2015.129","article-title":"Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type","volume":"29","year":"2016","journal-title":"Mod Pathol"},{"key":"2021112406072043000_4.5.a002956.14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000475"},{"key":"2021112406072043000_4.5.a002956.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.pgp.0000139644.38835.9d"},{"key":"2021112406072043000_4.5.a002956.16","unstructured":"McCluggage WG , Daya F , Ip P , Malpica A , Oliva E , Young RH . 2014. Miscellaneous tumors. In WHO classification of tumours of female reproductive organs, 4th ed. (ed. Kurman RJ , Carcangiu ML , Herrington CS , Young RH ), pp. 70\u201371. International Agency for Research on Cancer, Lyon, France."},{"key":"2021112406072043000_4.5.a002956.17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2928"},{"key":"2021112406072043000_4.5.a002956.18","doi-asserted-by":"crossref","first-page":"djv351","DOI":"10.1093\/jnci\/djv351","article-title":"Germline findings in tumor-only sequencing: points to consider for clinicians and laboratories","volume":"108","author":"Clinical Sequencing Exploratory Research Consortium Tumor Working Group","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2021112406072043000_4.5.a002956.19","unstructured":"Scully RE . 1979. Tumors of the ovary and maldeveloped gonads. In Atlas of tumor pathology (ed. Hartmann WH , Cowan WR ), second series, fascicle 16, pp. 239\u2013312. Armed Forces of Institute of Pathology, Washington, DC."},{"key":"2021112406072043000_4.5.a002956.20","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.06004"},{"key":"2021112406072043000_4.5.a002956.21","doi-asserted-by":"publisher","DOI":"10.1002\/path.4585"},{"key":"2021112406072043000_4.5.a002956.22","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2931"},{"key":"2021112406072043000_4.5.a002956.23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","article-title":"Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent developments on pathogenesis","volume":"9","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"2021112406072043000_4.5.a002956.24","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199411000-00004"}],"container-title":["Molecular Case Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/mcs.a002956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T14:11:12Z","timestamp":1637763072000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularcasestudies.cshlp.org\/lookup\/doi\/10.1101\/mcs.a002956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,10,1]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1101\/mcs.a002956"],"URL":"https:\/\/doi.org\/10.1101\/mcs.a002956","relation":{},"ISSN":["2373-2865","2373-2873"],"issn-type":[{"value":"2373-2865","type":"print"},{"value":"2373-2873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}